Ioannidis and Garber describe personalised cost-effectiveness for treatments

John Ioannidis and Alan Garber, both from Stanford, have just published a new and interesting article in PLoS Medicine on individualised cost-effectiveness analysis. They think (and I agree) that knowing that it costs $8.60 to get 20 extra days without the flu is worthwhile. Especially when another example says that people over 45 with knee … Continue reading Ioannidis and Garber describe personalised cost-effectiveness for treatments

PLoS Medicine becomes more interested in research translation

PLoS Medicine: WHO/PLoS Collection “No Health Without Research”: A Call for Papers This is particularly good news for those of us interested in the translation of evidence into practice in medicine. Some of the discussions that PLoS Medicine have listed as desirable include issues around ethics in research, and models of research network organisation.